Literature DB >> 21917193

Body size at birth modifies the effect of fat mass and obesity associated (FTO) rs9939609 polymorphism on adiposity in adolescents: the Healthy Lifestyle in Europe by Nutrition in Adolescence (HELENA) study.

Idoia Labayen1, Jonatan R Ruiz, Francisco B Ortega, Frédéric Gottrand, Inge Huybrechts, Jean Dallongeville, Kurt Widhalm, Marika Ferrari, Annete Buyken, Mathilde Kersting, George Moschonis, Dominique Turck, Sonia Gómez, Michael Sjostrom, Aline Meirhaeghe, Luis A Moreno.   

Abstract

The present study was intended to examine whether ponderal index (PI) at birth modifies the effect of the fat mass and obesity associated (FTO) rs9939609 polymorphism on adiposity in European adolescents. A total of 628 adolescents aged 14·4 (se 1·3) years (56·8 % female) were recruited. PI was calculated from parental reports of birth weight and length (kg/m³), and the BMI (kg/m²), body fat percentage and fat mass index (FMI, kg/m²) were calculated. The rs9939609 polymorphism was genotyped and physical activity assessed by accelerometry. Sex, duration of pregnancy, pubertal status, centre and physical activity were used as confounders in all the analyses. The minor A allele of the FTO rs9939609 was significantly associated with higher BMI, body fat percentage and FMI (all P < 0·05) but not with PI. Significant interactions between PI and the rs9939609 polymorphism in terms of body fat percentage (P = 0·002) and FMI (P = 0·017) were detected. However, this polymorphism was only significantly associated with higher BMI, body fat percentage and FMI (all P < 0·05) in adolescents in the lower PI tertile. Indeed, both body fat percentage and FMI were higher in those adolescents in the lower PI tertile carrying the A allele of the FTO rs9939609 polymorphism than in those with the TT genotype (25·0 (se 0·8) v. 22·1 (se 1·0) %, adjusted P = 0·030 and 5·6 (se 0·3) v. 4·6 (se 0·4) kg/m2, P = 0·031, respectively). Our findings suggest that those adolescents born with lower PI could be more vulnerable to the influence of the A risk allele of the FTO polymorphism on total adiposity content.

Entities:  

Mesh:

Year:  2011        PMID: 21917193     DOI: 10.1017/S0007114511004600

Source DB:  PubMed          Journal:  Br J Nutr        ISSN: 0007-1145            Impact factor:   3.718


  5 in total

1.  Maternal and neonatal FTO rs9939609 polymorphism affect insulin sensitivity markers and lipoprotein profile at birth in appropriate-for-gestational-age term neonates.

Authors:  Eva Gesteiro; Francisco J Sánchez-Muniz; Carolina Ortega-Azorín; Marisa Guillén; Dolores Corella; Sara Bastida
Journal:  J Physiol Biochem       Date:  2016-02-06       Impact factor: 4.158

Review 2.  Nutrition and lifestyle in european adolescents: the HELENA (Healthy Lifestyle in Europe by Nutrition in Adolescence) study.

Authors:  Luis A Moreno; Frédéric Gottrand; Inge Huybrechts; Jonatan R Ruiz; Marcela González-Gross; Stefaan DeHenauw
Journal:  Adv Nutr       Date:  2014-09       Impact factor: 8.701

3.  Influence of FTO variants on obesity, inflammation and cardiovascular disease risk biomarkers in Spanish children: a case-control multicentre study.

Authors:  Josune Olza; Azahara I Ruperez; Mercedes Gil-Campos; Rosaura Leis; Dietmar Fernandez-Orth; Rafael Tojo; Ramon Cañete; Angel Gil; Concepcion M Aguilera
Journal:  BMC Med Genet       Date:  2013-12-01       Impact factor: 2.103

4.  The FTO rs9939609 and LEPR rs1137101 mothers-newborns gene polymorphisms and maternal fat mass index effects on anthropometric characteristics in newborns: A cross-sectional study on mothers-newborns gene polymorphisms-The FTO-LEPR Study (STROBE-compliant article).

Authors:  Claudiu Mărginean; Cristina Oana Mărginean; Mihaela Iancu; Lorena Elena Meliţ; Florin Tripon; Claudia Bănescu
Journal:  Medicine (Baltimore)       Date:  2016-12       Impact factor: 1.817

Review 5.  New Insights Regarding Genetic Aspects of Childhood Obesity: A Minireview.

Authors:  Cristina Oana Mǎrginean; Claudiu Mǎrginean; Lorena Elena Meliţ
Journal:  Front Pediatr       Date:  2018-10-04       Impact factor: 3.418

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.